Work

A phase III randomized double-blind study of prophylactic topical dapsone 5% versus moisturizer for cetuximab-induced papulopustular (acneiform) rash.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.tps9638

Authors: Mario E. Lacouture, Viswanath Reddy Belum, Danielle Kehn, Andrea Cercek, Nancy E. Kemeny

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Chemotherapy-related skin toxicity

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597945765

Cites:

Cited by: 1

Related to: 10